Dr. Vanheyst is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-8938
Education & Training
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalFellowship, Pediatric Hematology/Oncology, 2016 - 2019
- Stony Brook Medicine/University HospitalResidency, Pediatrics, 2012 - 2015
- NYIT College Of Osteopathic MedicineClass of 2012
Certifications & Licensure
- OH State License 2016 - 2025
- NY State License 2015 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.Sung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, Melissa Bonner, Saada Eid
Cancer Communications. 2024-08-01 - 3 citationsOral TGF-βR1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.Sung Hee Choi, Jay Myers, Suzanne Tomchuck, Melissa Bonner, Saada Eid
Research Square. 2023-04-03 - 11 citationsEctopic Tumor VCAM-1 Expression in Cancer Metastasis and Therapy Resistance.Kristen A VanHeyst, Sung Hee Choi, Daniel T Kingsley, Alex Y Huang
Cells. 2022-12-04
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: